171 related articles for article (PubMed ID: 25282581)
1. The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab.
Nordal HH; Brun JG; Halse AK; Jonsson R; Fagerhol MK; Hammer HB
BMC Musculoskelet Disord; 2014 Oct; 15():335. PubMed ID: 25282581
[TBL] [Abstract][Full Text] [Related]
2. The soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab.
Hammer HB; Fagerhol MK; Wien TN; Kvien TK
Arthritis Res Ther; 2011; 13(5):R178. PubMed ID: 22029973
[TBL] [Abstract][Full Text] [Related]
3. Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis.
Nordal HH; Brokstad KA; Solheim M; Halse AK; Kvien TK; Hammer HB
Arthritis Res Ther; 2017 Jan; 19(1):3. PubMed ID: 28081709
[TBL] [Abstract][Full Text] [Related]
4. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
Nordal HH; Brun JG; Hordvik M; Eidsheim M; Jonsson R; Halse AK
Scand J Rheumatol; 2016 Jul; 45(4):274-81. PubMed ID: 26767827
[TBL] [Abstract][Full Text] [Related]
5. Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.
Inciarte-Mundo J; Ramirez J; Hernández MV; Ruiz-Esquide V; Cuervo A; Cabrera-Villalba SR; Pascal M; Yagüe J; Cañete JD; Sanmarti R
Arthritis Res Ther; 2016 Jul; 18(1):160. PubMed ID: 27391315
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced ultrasonography is more sensitive than grayscale and power Doppler ultrasonography compared to MRI in therapy monitoring of rheumatoid arthritis patients.
Ohrndorf S; Hensch A; Naumann L; Hermann KG; Scheurig-Münkler C; Meier S; Burmester GR; Backhaus M
Ultraschall Med; 2011 Dec; 32 Suppl 2():E38-44. PubMed ID: 22052070
[TBL] [Abstract][Full Text] [Related]
7. Ultrasonography shows significant improvement in wrist and ankle tenosynovitis in rheumatoid arthritis patients treated with adalimumab.
Hammer HB; Kvien TK
Scand J Rheumatol; 2011 May; 40(3):178-82. PubMed ID: 21091275
[TBL] [Abstract][Full Text] [Related]
8. A 78-joints ultrasonographic assessment is associated with clinical assessments and is highly responsive to improvement in a longitudinal study of patients with rheumatoid arthritis starting adalimumab treatment.
Hammer HB; Sveinsson M; Kongtorp AK; Kvien TK
Ann Rheum Dis; 2010 Jul; 69(7):1349-51. PubMed ID: 20472599
[TBL] [Abstract][Full Text] [Related]
9. Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.
Hurnakova J; Zavada J; Hanova P; Hulejova H; Klein M; Mann H; Sleglova O; Olejarova M; Forejtova S; Ruzickova O; Komarc M; Vencovsky J; Pavelka K; Senolt L
Arthritis Res Ther; 2015 Sep; 17(1):252. PubMed ID: 26373925
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of 7- to 78-joint ultrasonography scores: all different joint combinations show equal response to adalimumab treatment in patients with rheumatoid arthritis.
Hammer HB; Kvien TK
Arthritis Res Ther; 2011 May; 13(3):R78. PubMed ID: 21619619
[TBL] [Abstract][Full Text] [Related]
11. Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis.
Iagnocco A; Finucci A; Ceccarelli F; Perricone C; Iorgoveanu V; Valesini G
Rheumatology (Oxford); 2015 Oct; 54(10):1890-6. PubMed ID: 26070937
[TBL] [Abstract][Full Text] [Related]
12. Clinical and ultrasonographic monitoring of response to adalimumab treatment in rheumatoid arthritis.
Iagnocco A; Filippucci E; Perella C; Ceccarelli F; Cassarà E; Alessandri C; Sabatini E; Grassi W; Valesini G
J Rheumatol; 2008 Jan; 35(1):35-40. PubMed ID: 18050384
[TBL] [Abstract][Full Text] [Related]
13. Correlation of radiographic progression with the cumulative activity of synovitis estimated by power Doppler ultrasound in rheumatoid arthritis: difference between patients treated with methotrexate and those treated with biological agents.
Ikeda K; Nakagomi D; Sanayama Y; Yamagata M; Okubo A; Iwamoto T; Kawashima H; Takahashi K; Nakajima H
J Rheumatol; 2013 Dec; 40(12):1967-76. PubMed ID: 24187096
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs.
Bugatti S; Manzo A; Benaglio F; Klersy C; Vitolo B; Todoerti M; Sakellariou G; Montecucco C; Caporali R
Arthritis Res Ther; 2012 Feb; 14(1):R34. PubMed ID: 22336440
[TBL] [Abstract][Full Text] [Related]
15. Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab.
Filippucci E; Iagnocco A; Salaffi F; Cerioni A; Valesini G; Grassi W
Ann Rheum Dis; 2006 Nov; 65(11):1433-7. PubMed ID: 16504996
[TBL] [Abstract][Full Text] [Related]
16. Presence of power Doppler synovitis in rheumatoid arthritis patients with synthetic and/or biological disease-modifying anti-rheumatic drug-induced clinical remission: experience from a Chinese cohort.
Geng Y; Han J; Deng X; Zhang Z
Clin Rheumatol; 2014 Aug; 33(8):1061-6. PubMed ID: 24777468
[TBL] [Abstract][Full Text] [Related]
17. Improvement of large-joint ultrasonographic synovitis is delayed in patients with newly diagnosed rheumatoid arthritis: results of a 12-month clinical and ultrasonographic follow-up study of a local cohort.
Harman H; Tekeoğlu İ; Takçı S; Kamanlı A; Nas K; Harman S
Clin Rheumatol; 2015 Aug; 34(8):1367-74. PubMed ID: 25833144
[TBL] [Abstract][Full Text] [Related]
18. Clinical and sonographic biomarkers of structural damage progression in RA patients in clinical remission: A prospective study with 12 months follow-up.
Ramírez J; Narváez JA; Ruiz-Esquide V; Hernández-Gañán J; Cuervo A; Inciarte-Mundo J; Hernández MV; Sampayo-Cordero M; Pablos JL; Sanmartí R; Cañete JD
Semin Arthritis Rheum; 2017 Dec; 47(3):303-309. PubMed ID: 28549731
[TBL] [Abstract][Full Text] [Related]
19. Generalized estimating equation model to compare drug effects on synovitis of the dominant wrist in severe rheumatoid arthritis between tocilizumab versus adalimumab versus abatacept using high-resolution ultrasound.
Chen YC; Chiu WC; Su FM; Chen JF
Int J Rheum Dis; 2018 Sep; 21(9):1695-1700. PubMed ID: 29024421
[TBL] [Abstract][Full Text] [Related]
20. Relation of Doppler ultrasound synovitis versus clinical synovitis with changes in native complement component levels in rheumatoid arthritis patients treated with biologic disease-modifying anti-rheumatic drugs.
Montoro Alvarez M; Chong OY; Janta I; González C; López-Longo J; Monteagudo I; Valor L; Garrido J; Lau IS; Rosman A; Naredo E; Carreño L
Clin Exp Rheumatol; 2015; 33(2):141-5. PubMed ID: 25665178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
